Study links mRNA jabs to excess cancer deaths in Japan

For several years, oncologists such as Prof Angus Dalgleish have been linking mRNA Covid vaccines to cancer onset/relapse. Of course, the pro-mRNA side have consistently dismissed such worries as nothing more than anecdotes and coincidences. However, population-level data supporting this link has appeared in a new peer-reviewed study titled “Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan.”

The authors start by pointing out that age-adjusted mortality rates (AMRs) for all cancers continued their downward trend during the first year of the Covid Pandemic right up until the roll-out of the Covid jabs. A rather unfortunate coincidence, I’m sure you’ll agree.

Figure 1: Age-adjusted mortality rates (AMRs) over time and excess mortality in each month: all cancers.

The age-groups found to have had statistically significant excess cancer deaths were 75-79 year olds in 2020, 2021, and 2022 and 80-84 year olds in 2022, with both groups showing year-on-year increases. Both groups incidentally also had booster rates over 90%.

Figure 2: Excess mortality during the pandemic in 2020, 2021, and 2022 (upper) and crude cancer deaths in 2022 (lower) in each age group.

So far, so coincidental. It’s important to stress here that only 5 out of 20 cancers showed any excess deaths in 2020-2022. But the 3 that showed significant excess deaths in 2021 (pancreatic, prostate, and ovarian cancers) coincidentally showed significant excess deaths in 2022 too. I guess that’s at least 3 more unfortunate coincidences. Lip/oral/pharygeal cancers and leukemia also showed significant excess deaths in 2022.

Figure 3: Excess mortality for each cancer type during the pandemic in 2020, 2021, and 2022.

Figure 5: Age-adjusted mortality rates (AMRs) over time and excess mortality in each month for cancers with excess mortalities in 2021 and 2022.

Discussing possible mechanisms to explain these results, the authors mention a long list issues with the mRNA shots: lipid nanoparticles spreading to various organs, long-lasting spike proteins in the blood, thrombosis, suppression of type I interferon responses “which play an essential role in cancer immunosurveillance”, increased IgG4 antibodies, reactivation of latent viruses, and reverse-transcription of mRNA into DNA and integration into the human genome. On the last point, the authors quote our old friends at the FDA.

The U.S. Food and Drug Administration (FDA) states in its guidance for the production of viral vaccines for infectious disease, "There are several potential mechanisms by which residual DNA could be oncogenic, including the integration and expression of encoded oncogenes or insertional mutagenesis following DNA integration" [98]. The FDA's guidelines are essential for Japan because Japan's special emergency use authorization depended on FDA approval during the COVID-19 pandemic

If the FDA is Dr Evil, Japan’s Ministry of Health is Mini-me. But not as funny.